Literature DB >> 26672785

Metastasis: Resistance fighters.

Neil Savage.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26672785     DOI： 10.1038/528S128a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.

Authors:  Liang Dai; Zi-Xuan Song; Da-Peng Wei; Ji-Dong Zhang; Jun-Qiang Liang; Bai-Bing Wang; Wang-Teng Ma; Li-Ying Li; Yin-Lu Dang; Liang Zhao; Li-Min Zhang; Yu-Ming Zhao
Journal:  Adv Ther       Date:  2021-04-21       Impact factor: 3.845

Review 2.  RNA splicing and splicing regulator changes in prostate cancer pathology.

Authors:  Jennifer Munkley; Karen Livermore; Prabhakar Rajan; David J Elliott
Journal:  Hum Genet       Date:  2017-04-05       Impact factor: 4.132

3.  Exo70 is an independent prognostic factor in colon cancer.

Authors:  Li Xiao; Kaifeng Zheng; Xia Lv; Jihuan Hou; Liang Xu; Yujie Zhao; Fei Song; Yaqiong Fan; Hanwei Cao; Wenqing Zhang; Xiaoting Hong; Yan-Yan Zhan; Tianhui Hu
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

4.  Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.

Authors:  Ju Mi Jeon; Oh Kwang Kwon; Ann-Yae Na; Eun Ji Sung; Il Je Cho; Mirae Kim; Sung Su Yea; So Young Chun; Jun Hyung Lee; Yun-Sok Ha; Tae Gyun Kwon; Sangkyu Lee
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.